Tanvex BioPharma (6541.TW) Q3 2026 Earnings

6AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-1.69
-1.49
-1.3
-1.1

Details

Expected EPS
-1.68610063899
Actual EPS
N/A
Surprise EPS
1.69
Surprise Percent
+100%

Description

Tanvex BioPharma (6541.TW) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts